Holmium Laser Enucleation of the Prostate (HoLEP) is a minimally invasive laser procedure used to treat urinary symptoms caused by an enlarged prostate, medically known as benign prostatic hyperplasia (BPH).
The procedure uses a holmium laser to separate and remove the enlarged prostate tissue that is blocking urine flow. HoLEP can be considered for men with significant prostate enlargement and bothersome urinary symptoms when surgical treatment is recommended.
HoLEP stands for Holmium Laser Enucleation of the Prostate. It is an endoscopic prostate surgery used to remove the enlarged inner portion of the prostate that obstructs the urinary passage.
During HoLEP, a specialized instrument is passed through the urinary passage, so there is no external surgical incision. A holmium laser is used to separate the obstructing prostate tissue from the surrounding prostate capsule. The removed tissue is then fragmented and taken out of the bladder.
Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that commonly occurs with increasing age. As the prostate enlarges, it can narrow the urinary passage and make it more difficult for urine to flow from the bladder.
BPH does not mean prostate cancer. However, significant prostate enlargement can cause persistent urinary symptoms and, in some patients, complications affecting the bladder or urinary tract.
BPH can cause lower urinary tract symptoms that affect urination, bladder emptying and quality of life. Symptoms can vary from person to person.
Urine may flow more slowly or with less force than before.
Some men may have difficulty initiating urination or may need to wait before the urine starts flowing.
An enlarged prostate may be associated with a frequent need to pass urine, including during the night.
A sudden or difficult-to-control urge to urinate may occur.
A feeling that the bladder has not completely emptied after urination may occur.
Severe obstruction can sometimes result in an inability to pass urine, requiring urgent medical attention.
Prostate enlargement is associated with age-related changes in prostate tissue. The exact degree of enlargement and the severity of urinary symptoms can differ between individuals.
A urologist evaluates urinary symptoms, medical history and prostate-related findings before deciding whether medicines, monitoring or surgery may be appropriate.
HoLEP is not required for every man with an enlarged prostate. Many patients with mild or moderate symptoms can initially be managed with lifestyle measures, monitoring or medicines.
Surgical treatment may be considered when urinary obstruction is significant, symptoms remain troublesome despite medical treatment, or complications related to BPH develop.
The decision to undergo HoLEP depends on symptoms, prostate size, urinary obstruction, previous treatment, medical history and urological assessment. Not every patient with BPH requires laser surgery.
Treatment for BPH is individualized. Depending on symptom severity, prostate size, bladder function and other clinical factors, different treatment options may be considered.
Selected patients with mild symptoms may benefit from lifestyle and fluid-management measures along with medical monitoring.
Medicines may be prescribed to improve urine flow, relax prostate-related obstruction or reduce prostate size depending on the clinical situation.
Transurethral resection of the prostate removes obstructing prostate tissue through the urinary passage.
Holmium laser technology is used to enucleate obstructive prostate tissue through a minimally invasive endoscopic approach.
Depending on the patient's condition, prostate size and availability, other minimally invasive or surgical treatments may also be considered.
HoLEP is performed through the urinary passage using a specialized endoscopic instrument. The exact surgical technique may vary according to prostate size, anatomy and the surgeon's assessment.
The patient's symptoms, prostate size, urinary flow, bladder emptying, medical history and relevant investigations are reviewed.
HoLEP is generally performed under appropriate anesthesia with continuous monitoring during the procedure.
A specialized instrument is introduced through the urinary passage to reach the prostate. No external skin incision is required.
A holmium laser is used to separate the enlarged obstructive prostate tissue from the surrounding prostate capsule.
The enucleated prostate tissue is moved into the bladder and broken into smaller pieces using a specialized morcellation instrument.
The fragmented prostate tissue is removed from the bladder. Tissue may be sent for laboratory examination when required.
A urinary catheter is generally placed temporarily after the procedure to allow urine drainage and bladder recovery.
Proper preparation helps the surgical team assess the patient's overall health and plan the procedure safely.
Recovery after HoLEP varies between patients and depends on prostate size, individual health, the complexity of the procedure and postoperative recovery.
A urinary catheter is commonly used temporarily after surgery and is removed when the treating team considers it appropriate.
Mild blood in the urine, urinary frequency or urgency can occur during the early recovery period and generally improves with healing.
Light activity is generally resumed first, while strenuous physical activity should be avoided until medically cleared.
Follow-up allows the urologist to assess urinary symptoms, urine flow, bladder emptying and overall recovery.
Some patients experience temporary urinary urgency, frequency, burning or mild blood in the urine during the early recovery period. These symptoms can occur while the urinary passage and bladder adjust after removal of the obstructing prostate tissue.
Symptoms generally improve with healing, although the recovery pattern varies between individuals. Persistent, severe or worsening symptoms should be discussed with the treating urologist.
HoLEP is performed through the urinary passage without an external surgical incision.
The enucleation technique allows the obstructive prostate tissue to be separated and removed.
HoLEP can be considered in patients with significantly enlarged prostates who require surgical treatment.
Holmium laser technology provides precise tissue cutting and coagulation during the procedure.
Depending on the individual case and recovery, patients may have a relatively short hospital stay.
Removal of the obstructive prostate tissue can provide lasting improvement in urinary obstruction for appropriately selected patients.
HoLEP and TURP are both endoscopic surgical treatments for urinary obstruction caused by an enlarged prostate. The techniques differ in how the obstructive prostate tissue is removed.
HoLEP is a minimally invasive surgical procedure, but like any medical procedure, it can have potential risks. The likelihood of complications varies according to individual health, prostate characteristics and surgical factors.
After surgery, contact your treating medical team promptly if you develop high fever, severe or worsening pain, heavy or persistent bleeding, inability to pass urine, persistent vomiting or other concerning symptoms.
HoLEP is designed to relieve urinary obstruction caused by an enlarged prostate. Patients should discuss sexual health and expectations with their urologist before surgery.
Changes in ejaculation can occur after prostate surgery, including retrograde ejaculation, where semen enters the bladder rather than being expelled normally. Erectile function outcomes vary between individuals and should be discussed as part of the preoperative consultation.
The main objective of HoLEP is to remove the obstructive prostate tissue and improve urinary flow and bladder emptying in appropriately selected patients.
Improvement in urinary symptoms may occur progressively as the urinary passage and bladder recover. The final outcome depends on factors such as prostate size, bladder function, severity and duration of obstruction, overall health and individual healing.
Regular follow-up after HoLEP helps the urologist assess urinary symptoms, urine flow and bladder emptying and identify any postoperative concerns that may require treatment.
The cost of HoLEP surgery can vary from patient to patient depending on the prostate size, clinical complexity, hospital charges and treatment requirements.
A personalized estimate can be discussed after evaluation of the patient's symptoms, prostate findings, investigations and treatment plan.
HoLEP stands for Holmium Laser Enucleation of the Prostate. It is a minimally invasive procedure that uses a holmium laser to remove obstructive prostate tissue in patients with enlarged prostate.
HoLEP is primarily used to treat urinary obstruction and bothersome lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH).
HoLEP can be considered for patients with significantly enlarged prostates who require surgical treatment. The appropriate procedure depends on individual evaluation.
Yes. HoLEP is performed through the urinary passage using an endoscopic instrument and does not require an external surgical incision.
The holmium laser is used to enucleate the obstructive prostate tissue. The tissue is then moved into the bladder, morcellated into smaller pieces and removed.
A urinary catheter is generally placed temporarily after surgery. The duration depends on the procedure and the patient's recovery.
Recovery varies between patients. Urinary frequency, urgency or mild blood in the urine may occur temporarily and usually improves as healing progresses.
Temporary urinary leakage can occur in some patients after surgery. The recovery pattern varies and persistent symptoms should be discussed with the treating urologist.
Yes. Changes in ejaculation, including retrograde ejaculation, can occur after prostate surgery. This should be discussed before treatment.
HoLEP and TURP are different surgical techniques for treating prostate obstruction. The appropriate procedure depends on prostate size, symptoms, anatomy, medical history and the urologist's assessment.
HoLEP may be considered in selected patients with urinary retention caused by prostate obstruction when surgical treatment is appropriate.
HoLEP removes the obstructive portion of the prostate, and significant regrowth requiring treatment is generally uncommon. Long-term urinary symptoms can also be influenced by bladder and other urinary conditions.
You should consult a urologist if you have persistent weak urine flow, difficulty urinating, frequent nighttime urination, incomplete bladder emptying, recurrent urinary infections or urinary retention.
Dr. Yash R. Godbole is a Consultant Urologist & Andrologist providing evaluation and treatment for prostate and urinary conditions, including minimally invasive urological procedures.
Consult Dr. Yash R. Godbole for evaluation of enlarged prostate, urinary symptoms and discussion of appropriate treatment options, including HoLEP when clinically suitable.
Medical Disclaimer: The information provided on this page is for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis or treatment. The appropriate prostate treatment depends on individual symptoms, prostate size, urinary findings, medical history and clinical evaluation. Please consult a qualified urologist for personalized medical advice.